Entry |
|
Name |
Volociximab (USAN) |
Formula |
C6434H9942N1706O2040S52
|
Exact mass |
145409.2142
|
Mol weight |
145499.47
|
Efficacy |
Aging-related macular degeneration therapeutic agent, Antineoplastic, Angiogenesis inhibitor, Anti-alpha5beta1 integrin antibody |
Type |
Monoclonal antibody |
Comment |
Treatment of solid tumors and age-related macular degeneration
|
Target |
|
Pathway |
hsa04810 | Regulation of actin cytoskeleton |
|
Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: other families
Integrins
ITGA5/ITGB1
D06319 Volociximab (USAN)
|
Other DBs |
|